These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 35163323)
1. Selective Boosting of CCR7-Acting Chemokines; Short Peptides Boost Chemokines with Short Basic Tails, Longer Peptides Boost Chemokines with Long Basic Tails. Brandum EP; Jørgensen AS; Calvo MB; Spiess K; Peterson FC; Yang Z; Volkman BF; Veldkamp CT; Rosenkilde MM; Goth CK; Hjortø GM Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163323 [TBL] [Abstract][Full Text] [Related]
2. The C-terminal peptide of CCL21 drastically augments CCL21 activity through the dendritic cell lymph node homing receptor CCR7 by interaction with the receptor N-terminus. Jørgensen AS; Brandum EP; Mikkelsen JM; Orfin KA; Boilesen DR; Egerod KL; Moussouras NA; Vilhardt F; Kalinski P; Basse P; Chen YH; Yang Z; Dwinell MB; Volkman BF; Veldkamp CT; Holst PJ; Lahl K; Goth CK; Rosenkilde MM; Hjortø GM Cell Mol Life Sci; 2021 Nov; 78(21-22):6963-6978. PubMed ID: 34586443 [TBL] [Abstract][Full Text] [Related]
3. Biased Signaling of CCL21 and CCL19 Does Not Rely on N-Terminal Differences, but Markedly on the Chemokine Core Domains and Extracellular Loop 2 of CCR7. Jørgensen AS; Larsen O; Uetz-von Allmen E; Lückmann M; Legler DF; Frimurer TM; Veldkamp CT; Hjortø GM; Rosenkilde MM Front Immunol; 2019; 10():2156. PubMed ID: 31572374 [TBL] [Abstract][Full Text] [Related]
4. Common and biased signaling pathways of the chemokine receptor CCR7 elicited by its ligands CCL19 and CCL21 in leukocytes. Hauser MA; Legler DF J Leukoc Biol; 2016 Jun; 99(6):869-82. PubMed ID: 26729814 [TBL] [Abstract][Full Text] [Related]
6. Fluorescently Tagged CCL19 and CCL21 to Monitor CCR7 and ACKR4 Functions. Purvanov V; Matti C; Samson GPB; Kindinger I; Legler DF Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30518137 [TBL] [Abstract][Full Text] [Related]
7. Arrestin 3 mediates endocytosis of CCR7 following ligation of CCL19 but not CCL21. Byers MA; Calloway PA; Shannon L; Cunningham HD; Smith S; Li F; Fassold BC; Vines CM J Immunol; 2008 Oct; 181(7):4723-32. PubMed ID: 18802075 [TBL] [Abstract][Full Text] [Related]
8. Dendritic cell chemotaxis in 3D under defined chemokine gradients reveals differential response to ligands CCL21 and CCL19. Haessler U; Pisano M; Wu M; Swartz MA Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5614-9. PubMed ID: 21422278 [TBL] [Abstract][Full Text] [Related]
9. Heparin Specifically Interacts with Basic BBXB Motifs of the Chemokine CCL21 to Define CCR7 Signaling. Artinger M; Gerken OJ; Legler DF Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675182 [TBL] [Abstract][Full Text] [Related]
11. Transferring the C-terminus of the chemokine CCL21 to CCL19 confers enhanced heparin binding. Barmore AJ; Castex SM; Gouletas BA; Griffith AJ; Metz SW; Muelder NG; Populin MJ; Sackett DM; Schuster AM; Veldkamp CT Biochem Biophys Res Commun; 2016 Sep; 477(4):602-606. PubMed ID: 27338641 [TBL] [Abstract][Full Text] [Related]
12. The expression of chemokines CCL19, CCL21 and their receptor CCR7 in oral squamous cell carcinoma and its relevance to cervical lymph node metastasis. Oliveira-Neto HH; de Souza PP; da Silva MR; Mendonça EF; Silva TA; Batista AC Tumour Biol; 2013 Feb; 34(1):65-70. PubMed ID: 22976543 [TBL] [Abstract][Full Text] [Related]
14. Combinatorial guidance by CCR7 ligands for T lymphocytes migration in co-existing chemokine fields. Nandagopal S; Wu D; Lin F PLoS One; 2011 Mar; 6(3):e18183. PubMed ID: 21464944 [TBL] [Abstract][Full Text] [Related]
15. Stimulation of osteoclast migration and bone resorption by C-C chemokine ligands 19 and 21. Lee J; Park C; Kim HJ; Lee YD; Lee ZH; Song YW; Kim HH Exp Mol Med; 2017 Jul; 49(7):e358. PubMed ID: 28729639 [TBL] [Abstract][Full Text] [Related]
16. Biased signaling of G protein-coupled receptors - From a chemokine receptor CCR7 perspective. Jørgensen AS; Rosenkilde MM; Hjortø GM Gen Comp Endocrinol; 2018 Mar; 258():4-14. PubMed ID: 28694053 [TBL] [Abstract][Full Text] [Related]
17. Analysis of migratory and prosurvival pathways induced by the homeostatic chemokines CCL19 and CCL21 in B-cell chronic lymphocytic leukemia. Cuesta-Mateos C; López-Giral S; Alfonso-Pérez M; de Soria VG; Loscertales J; Guasch-Vidal S; Beltrán AE; Zapata JM; Muñoz-Calleja C Exp Hematol; 2010 Sep; 38(9):756-64, 764.e1-4. PubMed ID: 20488224 [TBL] [Abstract][Full Text] [Related]
18. Chemokines and common variable immunodeficiency; possible contribution of CCL19, CCL21 and CCR7 to immune dysregulation. Fevang B; Yndestad A; Damås JK; Halvorsen B; Holm AM; Beiske K; Aukrust P; Frøland SS Clin Exp Immunol; 2009 Nov; 158(2):237-45. PubMed ID: 19747210 [TBL] [Abstract][Full Text] [Related]
19. Increased levels of CCR7 ligands in carotid atherosclerosis: different effects in macrophages and smooth muscle cells. Halvorsen B; Dahl TB; Smedbakken LM; Singh A; Michelsen AE; Skjelland M; Krohg-Sørensen K; Russell D; Höpken UE; Lipp M; Damås JK; Holm S; Yndestad A; Biessen EA; Aukrust P Cardiovasc Res; 2014 Apr; 102(1):148-56. PubMed ID: 24518141 [TBL] [Abstract][Full Text] [Related]
20. Differential desensitization, receptor phosphorylation, beta-arrestin recruitment, and ERK1/2 activation by the two endogenous ligands for the CC chemokine receptor 7. Kohout TA; Nicholas SL; Perry SJ; Reinhart G; Junger S; Struthers RS J Biol Chem; 2004 May; 279(22):23214-22. PubMed ID: 15054093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]